Bank of America’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-20
Closed -$175 8468
2024
Q1
$175 Buy
+20
New +$154 ﹤0.01% 7354
2022
Q4
Sell
-50
Closed -$1K 8478
2022
Q3
$1K Hold
50
﹤0.01% 7705
2022
Q2
$1K Buy
+50
New +$1.25K ﹤0.01% 7902
2022
Q1
Hold
0
8858
2021
Q4
Sell
-38
Closed -$2K 8712
2021
Q3
$3K Sell
38
-40
-51% -$2.84K ﹤0.01% 7848
2021
Q2
$7K Sell
78
-14
-15% -$1.33K ﹤0.01% 7378
2021
Q1
$11K Buy
92
+20
+28% +$2.22K ﹤0.01% 6995
2020
Q4
$3K Buy
72
+20
+38% +$740 ﹤0.01% 6908
2020
Q3
$2K Buy
52
+40
+333% +$1.77K ﹤0.01% 6718
2020
Q2
$1K Buy
12
+7
+140% +$641 ﹤0.01% 6760
2020
Q1
$0 Sell
5
-5
-50% -$456 ﹤0.01% 7309
2019
Q4
$1K Hold
10
﹤0.01% 6985
2019
Q3
$1K Buy
+10
New +$2.17K ﹤0.01% 7150
2019
Q2
Hold
0
7453
2019
Q1
Hold
0
7461
2018
Q4
Hold
0
7429
2018
Q3
Hold
0
7508
2018
Q2
Sell
-4
Closed -$737 7369
2018
Q1
$1K Buy
+4
New +$783 ﹤0.01% 6994
2017
Q4
Sell
-1
Closed -$208 7294
2017
Q3
$0 Buy
+1
New +$184 ﹤0.01% 7322
2017
Q2
Hold
0
7214
2017
Q1
Hold
0
7282
2016
Q4
Hold
0
7361
2016
Q3
Sell
-14
Closed -$4.91K 7405
2016
Q2
$5K Sell
14
-29
-67% -$10.4K ﹤0.01% 6685
2016
Q1
$14K Sell
43
-4
-9% -$1.32K ﹤0.01% 6281
2015
Q4
$21K Buy
+47
New +$29.5K ﹤0.01% 6406
2015
Q3
Hold
0
7439
2015
Q2
Sell
-2
Closed -$8.43K 7437
2015
Q1
$9K Buy
+2
New +$11.5K ﹤0.01% 6331
2014
Q4
Sell
-2
Closed -$23K 8013
2014
Q3
$23K Buy
+2
New +$25.6K ﹤0.01% 6971
2014
Q2
Hold
0
8250
2014
Q1
Hold
0
8121
2013
Q4
Hold
0
8177
2013
Q3
Hold
0
-$3K 8060
2013
Q2
Hold
0
7465

Other funds holding CSCI

Bank of America's CSCI Position: Q2 2024 in Review

Bank of America sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q2 2024, closing a stake of 20 shares — an estimated $175 sold.

Bank of America first reported a position in CSCI in Q3 2014 and held it in 19 quarters. The position peaked at $23K in Q3 2014. 13 funds tracked by Wall St. Rank hold CSCI as of Q2 2024.

  • Bank of America reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Bank of America sold 20 COSCIENS Biopharma Inc. Common Stock shares in Q2 2024, an estimated $175.
  • Bank of America first reported a position in COSCIENS Biopharma Inc. Common Stock in Q3 2014 and held it in 19 quarters.
  • Bank of America's COSCIENS Biopharma Inc. Common Stock position peaked at $23K in Q3 2014.
  • 13 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q2 2024.

Based on Bank of America's 13F filing for Q2 2024, filed 14 Aug 2024.